BRWA
ELOX

B. Riley Wealth Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

B. Riley Wealth Advisors’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-963
Closed -$7K – 1625
2022
Q3 		$7K Buy
+963
New +$11.6K ﹤0.01% 1440

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

B. Riley Wealth Advisors's ELOX Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 963 shares — an estimated $7K sold.

B. Riley Wealth Advisors first reported a position in ELOX in Q3 2022 and held it in 1 quarter. The position peaked at $7K in Q3 2022. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 963 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $7K.
  • B. Riley Wealth Advisors first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q3 2022.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.